ADVANCED BILIARY TRACT ADENOCARCINOMA

Clinical trials for ADVANCED BILIARY TRACT ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED BILIARY TRACT ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED BILIARY TRACT ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New combo therapy hopes to tackle tough bile duct cancer

Disease control Recruiting now

This phase 2 trial is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy or the targeted drug lenvatinib can help people with advanced biliary tract cancer live longer and control their tumors better. The study will enroll 60 adults whose cancer …

Matched conditions: ADVANCED BILIARY TRACT ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

ADVANCED BILIARY TRACT ADENOCARCINOMA

Get alerted when new ADVANCED BILIARY TRACT ADENOCARCINOMA trials appear

New combo therapy hopes to tackle tough bile duct cancer